Briseid K, Ryssdal A B
Acta Pharmacol Toxicol (Copenh). 1980 Sep;47(3):161-70. doi: 10.1111/j.1600-0773.1980.tb01554.x.
Incubation of plasma from rats pretreated with tranexamic acid (40 mg/100 g) with acetone (23% V/V) yielded enzyme preparations in which all the plasminogen present was recovered as plasmin and a plasmin-like substance without affinity for lysine-Sepharose. This substance, designated "plasmin", was separated from plasmin and kallikrein in a three-step procedure using columns of lysine-Sepharose, DEAE-Sephadex A-50, and arginine-Sepharose. The ratios of fibrinolytic, caseinolytic, LEe esterase, BAEe esterase and kininogenase activities of "plasmin" corresponded well with those of rat plasmin and human plasmin. Both rat plasmin and "plasmin" destroyed the capacity of high molecular weight kininogen (HMWK) to function as a cofactor in the activation of factor XII in rat plasma, without causing a corresponding release of the kinin part of the molecule. Rat plasma kallikrein induced full release of kinin from HMWK, but the functional capacity was retained. It is suggested that the reduced extent of activation of factor XII observed in plasma from rats injected intravenously with dextran, or rat plasma that has been passed through a column with lysine-Sepharose, is due to the loss of functional HMWK caused by plasmin activated in vivo or on the column.
用氨甲环酸(40mg/100g)预处理大鼠后所得血浆与丙酮(23%V/V)孵育,得到酶制剂,其中所有存在的纤溶酶原均以纤溶酶和一种对赖氨酸 - 琼脂糖无亲和力的类纤溶酶物质形式回收。这种物质被命名为“纤溶酶”,通过使用赖氨酸 - 琼脂糖柱、DEAE - 葡聚糖A - 50柱和精氨酸 - 琼脂糖柱的三步程序与纤溶酶和激肽释放酶分离。“纤溶酶”的纤维蛋白溶解、酪蛋白溶解、LEe酯酶、BAEe酯酶和激肽原酶活性的比率与大鼠纤溶酶和人纤溶酶的比率非常吻合。大鼠纤溶酶和“纤溶酶”均破坏了高分子量激肽原(HMWK)在大鼠血浆中作为因子XII激活辅因子的功能能力,但未导致该分子激肽部分的相应释放。大鼠血浆激肽释放酶可诱导HMWK中激肽完全释放,但功能能力得以保留。有人提出,在静脉注射右旋糖酐的大鼠血浆或通过赖氨酸 - 琼脂糖柱的大鼠血浆中观察到的因子XII激活程度降低,是由于体内或柱上激活的纤溶酶导致功能性HMWK丧失所致。